THERAPEUTIC INERTIA

Programs &
Events

Sharing the Latest in Diabetes Care

We partner with experts and other organizations to host events that can help you overcome therapeutic inertia. Explore our upcoming programs to learn the latest guidelines and developments in diabetes care and clinical practice.

Current and Upcoming Programs

Past Programs

Resources for OTI Clinical Workshops

Below are resources we recommend you review. These items will provide relevant background, including a grounding on the current state of therapeutic inertia and ADA's activities.

ADA offers a self-paced online continuing education (CE) program offering up to 22 CE credits or ABIM
MOC points to help you optimize care for people with diabetes. The certificate program includes
content from the popular Diabetes is Primary and Overcoming Therapeutic Inertia education initiatives.

As advances in diabetes treatment evolve at a rapid-fire pace, Diabetes Is Primary® targets clinicians on the frontlines of primary care. Diabetes Is Primary delivers easily accessible continuing education to meet the needs of busy primary care providers (PCP).

The program is based on the American Diabetes Association’s (ADA) Standards of Medical Care in Diabetes—the gold standard in diabetes treatment. These guidelines, updated annually, ensure that patients receive up-to-date, evidence-based care.

Additionally, Diabetes Is Primary helps PCPs navigate the complex changes in the health care industry, including new therapies and their costs, population health, and more.

Learn about ADA guidelines most relevant to primary care
Sharpen skills to individualize care based on specific patient needs
Understand the latest treatment options in a rapidly changing landscape
Improve patient outcomes with evidence-based strategies utilizing their entire care team

Diabetes Is Primary was developed by primary care providers for primary care providers. Last year’s attendees said:

97% felt the Diabetes Is Primary content gave them knowledge to improve their practice
91% plan on changing their practice as a result of what they learned
97% of survey respondents are likely to recommend Diabetes Is Primary to a colleague

“Excellent overall program. Very clinically oriented with lots of practical recommendations.”

“Exceeded my expectations. I learned so much.”

“This was truly one of the most informative conferences that I have attended, providing useful information and handouts that will positively affect my practice and confidence.”

Diabetes Is Primary is supported, in part, by educational grants from Abbott Diabetes Care, AstraZeneca, Merck, and Novo Nordisk.

Therapeutic inertia is responsible for substantial, preventable complications in type 2 diabetes with associated excess in direct and indirect health care costs. During this practical training, we will take an in-depth look at a single patient journey over more than 20 years, exploring best-practice approaches to both optimize diabetes care, reduce complications, and minimize therapeutic inertia.

More than 100 people representing a dozen different stakeholder groups met at the end of November 2018 to discuss the problem openly and honestly.

And now we have a roadmap to tackle the problem, but the journey has just started.

Become aware of what’s going on with the ADA initiative, Overcoming Therapeutic Inertia (OTI): Diabetes for Life

Summary of Proceedings

Download the Summit Agenda

Download the Participant Roster

The ADA’s OTI initiative is supported by Founding Sponsors Abbott, AstraZeneca, Merck, Novo Nordisk, and Sanofi, plus Strategic Sponsors Dexcom, Janssen, Lilly, and Medtronic.

Agenda and Slides

Presentation slides and summaries have been shared based on availability and permission from speakers. To view and download available presentations, click the corresponding session title or speaker name if there is more than one presenter.

Primary Care Clinician and Specialist Perspective
M. Sue Kirkman, MD
Sandra Leal, PharmD, MPH
Gretchen Youssef, MS, RD, CDE

Health System Perspective
Beth Averbeck, MD
Luigi Meneghini, MD, MBA

Industry Perspective
Rachele Berria, MD, PhD
Karmeen Kulkarni, MS, RD, BC-ADM, CDE
Rachele Berria, MD, PhD

Below are resources we recommend you review prior to attending an OTI Clinical Workshop in your area. These items will provide relevant background, including a grounding on the current state of therapeutic inertia and ADA's activities.

Preworkshop Reading:

Summary of Proceedings for 2018 Overcoming Therapeutic Inertia Summit

Therapeutic Inertia in Type 2 Diabetes: Prevalence, Causes, Consequences, and Methods to Overcome Inertia
Published May 3, 2019

Presentations from OTI Clinical Workshop—Phoenix (February 2020)

Optimizing Diabetes Care to Avoid Therapeutic Inertia
Eric L. Johnson, MD

Addressing Barriers to Self-Care That May Impact Therapeutic Inertia
Jenn Trujillo, PharmD, FCCP, BCPS, CDE, BC-ADM

Presentations from OTI Clinical Workshop—Baltimore (November 2019)

Keynote: Understanding Therapeutic Inertia in 2019: Why Should You Care?
Gretchen Youssef, MS, RD, CDE

Optimizing Diabetes Care to Avoid Therapeutic Inertia
Eden Miller, DO

Addressing Barriers to Self-Care That May Impact Therapeutic Inertia
Jenn Trujillo, PharmD, FCCP, BCPS, CDE, BC-ADM

Presentations from OTI Clinical Workshop—Los Angeles (October 2019)

Keynote: Understanding Therapeutic Inertia in 2019: Why Should You Care?
Stephen Brunton, MD, FAAFP